Zulu Investing: Would Jim Slater buy these 5 growth stocks?

Wednesday, Nov 23 2011 by
9
Zulu Investing Would Jim Slater buy these 5 growth stocks

“Investment is the art of the specific and selection is far more important than timing.”

Of the stalwarts of stock market investing, Jim Slater’s enduring appeal to UK private investors perhaps owes the most to his obvious affection for high quality but not overpriced growth companies. For the former City corporate raider, broadsheet columnist and children’s author, growth companies require careful and considered selection. After all, while buying into a growth story at the right moment and at the right price is paramount, these are companies that an investor could conceivably keep in a portfolio for very many years – come bulls and bears.

Never short of a forthright view and always amenable to sharing his views on stocks, Slater’s 1992 book The Zulu Principle has gone on to become a modern classic amongst private investors. In it, he not only sets out a carefully calibrated technique for measuring a company’s growth potential but he also encourages investors to do their own digging, to read between the lines and interpret information in a way that will give them an edge.

Start sieving

His approach starts by sieving the market for potential growth stock candidates and identifying which of them are attractively priced. The first hurdle for any company is ownership of a proven record of earnings per share (EPS) growth together with broker forecasts that the growth will continue by at least 15% over the next couple of years. “This gives you an arithmetical fix on the company,” Slater explains. Importantly, the stock must have four years of EPS growth – historic of forecast, or a combination of the two.

While scrutiny of past and future growth form the backbone of his screening technique, Slater’s commitment to the story behind a stock is what makes his approach intriguing to adopt. Investors are urged to scrutinise companies and filter the basket using a common sense set of criteria.

For instance, small, profitable companies with strong cashflow and low debt and signs of strength in their shares are important, while sectors that are less susceptible to cyclical patterns are preferred. Meanwhile, a competitive advantage, strong management and signs of optimism in the chairman’s statement are all pluses. Finally, a critical moment, such as a new CEO, as well as directors buying shares are also on the checklist.

PEG formula

On passing these criteria, a stock will face Slater’s most famous metric – the PEG, or the price-earnings growth factor, which measures how the price of a share relates to its earnings growth rate. He doesn’t much like the traditional use of the price-earnings (PE) ratio to value a share and prefers instead to study the relationship between the forward PE and the expected rate of EPS growth. His calculation is simple – divide the forward PE of a share by the estimated future growth rate in EPS to arrive at the PEG. Any share with a PEG over 1 gets short shrift from Slater while a score of 1 receives consideration and anything under 1 is worthy of much closer inspection.

It is worth stressing that Slater’s analysis concerns itself with the future performance of a stock according to broker forecasts. Whereas conventional PEG valuations popularised by the likes of Fidelity fund manager Peter Lynch, divide the trailing PE with the forecast EPS growth, Slater’s PEG uses the forward PE in its place. Investors and analysts have argued about the double counting of earnings growth in this method. Nevertheless, using Stockopedia Premium we have scanned all Main Market, AIM and PLUS market companies to see which of them are currently qualifying for closer inspection based on Slater’s Zulu Principle technique.

The top contender is Globo (LON:GBO), a company that develops and sells mobile, telecom and software systems to business customers. Established in Greece but with offices in seven countries, AIM listed Globo has consistently grown its net profits, and last year’s figures were up by 54% to £3.8 million. With strong EPS growth over five years, brokers are now forecasting forward EPS growth of 51% and a forward PE of just 3.79 – establishing a Slater PEG of 0.07. Slater would warm to news that chief executive Costis Papadimitrakopoulos has dipped into the market to buy shares on two occasions since the summer. Globo also matches the criteria set out by Slater for investing in smaller technology companies; the PEG has to be low, as does the multiple, and the company’s cashflow and liquidity are vital. Globo’s cashflow more than halved last year to £3.8 million, following an exceptional year in 2009, but nevertheless its liquidity ratio remained sound.

Moving on, Tim Dyson has spent nearly 20 years as CEO of public relations group Next Fifteen Communications (LON:NFC) but his embrace of digital innovation has proved decisive in protecting the company from harsh economic conditions. Next Fifteen produced record revenues and profits last year, together with five small acquisitions for a modest increase in debt. The shares had drifted from 84p to 73p since the end of the summer but bounced back in October and are now trading at closer to 85p – that recent spike in investor interest is an important factor in Slater’s criteria. With a forward PE of 8.45 and forecast EPS growth of 19.7%, Next Fifteen qualifies for a Slater PEG of 0.43.

Further down the list is First Derivatives (LON:FDP), the Northern Ireland based software and consulting group that develops data and trading systems for financial institutions. The company has been investing heavily in building an asset base and last year recorded a 44.2% rise in sales to £36.7 million as its target client base began recovering from the economic crash. Net profits have grown every year for the last five years and EPS is predicted to grow at a rate of 25.3%. With a forward PE of 10.5, First Derivatives achieves a Slater PEG of 0.42. The company carries a hefty debt pile of around £20 million, much of which is secured against a substantial property portfolio that it owns. Cash on the balance sheet more than doubled to £3.5 million last year but operating cashflows were dented as the group absorbed a substantial increase in headcount of 139 to 524.

Next up is Immunodiagnostic Systems (LON:IDH), a darling of AIM investors for its phenomenal share performance – rising over three years from 202p to a high of 1244p this summer. Despite recent falls in the price – now at around 770p – sales of the company’s diagnostic testing kits for the clinical and research markets continues to grow. Pre-tax profits were up last year by 51% at £16.6 million and the company made a point of slashing debt and focusing on cashflow. Last October, operations director Ian Cookson stepped up to take the helm as CEO and drive the company’s planned international expansion. As a healthcare stock, Slater would be a fan of IDS because of the perceived competitive advantages that companies can achieve through patented designs – in this case its recently introduced automated testing system, the IDS-iSYS. With a forward PE of 12.4 and forecast EPS growth of 20.9%, IDS achieves a Slater PEG of 0.59, putting it squarely on the Zulu radar. Of note, the only other healthcare stock on the Slater screen is Surgical Innovations (LON:SUN).

Finally, we have a stock that departs from the Zulu list of favoured sectors but nevertheless plays to the heart of Slater’s more recent investment thinking – gold mining. The first of two gold plays appearing on the screen is Pan African Resources (LON:PAF) but seeing as the South African miner recently triggered a price surge by indicating that some sort of significant deal could be in the pipeline, we have chosen the second stock, Highland Gold Mining (LON:HGM). Russia-focused Highland hit its target of producing 200,000 ounces of gold in 2010 and this year it wants to add a further 10-20,000 ounces. After paying off its debt early, the company is throwing off a great deal of cash – £60.6 million last year – while net profits grew by 52% to £78.4 million. With a forward PE of 6.26 and forecast EPS growth of 22.8%, the company boasts a Slater PEG of 0.27.

It won’t come as much surprise to hear that all of these stocks enjoy strong buy recommendations from brokers. With modest PE ratio forecasts and high EPS expectations, the numbers point to attractively priced companies that the brokers think will grow faster than the market. Slater does caveat the use of professional forecasts by encouraging investors to study in detail the story behind a stock. He also devised (and later sold) his own data service, Company REFS, to give investors access to the financial information they needed to identify growth companies. While arguments continue about Slater’s PEG formula, the technique – and the man – remain popular with investors.

How relevant is such a growth screen in the bleak times that Europe faces today? Good question - of course, no-one knows what the future holds. Still, we do see value in adhering to time-worn investing principles and strategies, be they growth or value, that look beyond the 24 hour newscycle, however grim. Now more than ever, investors need to apply careful and considered selection techniques to find those companies, if they are going to weather the vagaries of the market. We'll be tracking the performance of this screen closely to see how it fares...


Filed Under: Jim Slater, Investing,
There's value in the stock market
but do you know where to look?

Get the most concise synopsis of everything that's been proven to work in value investing. If you like your stocks cheap you've found a treasure trove distilled to under 70 pages.

  • How to find ultimate Bargain Stocks with Ben Graham
  • How to spot Turnarounds and avoid Value Traps
  • From Graham to Greenblatt via Piotroski & Lakonishok
  • How to value stocks and set a margin of safety

Soon to be retailing for an RRP of £14.99, for a limited time only,
you can get your copy free by joining our 35,000 strong mailing list.

*By signing up you'll be joining our mailing list
no junk, no spam - just great content like this example.


Disclaimer:  

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.


Do you like this Post?
Yes
No
9 thumbs up
0 thumbs down
Share this post with friends



Globo plc is engaged in the provision of telecom, mobile software products and related services, as well as developing and operating broadband wired and wireless networks. The Company operates in two segments: Mobile products and services and Telecom services (S.a.a.S). Its Mobile products and services segment in sells its own mobile software products and services to its clients. Its Telecom services (S.a.a.S) segment combines telecom services with its own software products (e-business and WiFi services) that are then sold on software as a service basis. The Company’s WiPLUS consists of a managed service provided to hotels, airports, marinas and similar locations with Globo receiving revenue from venue owners. The Company’s GO!Enterprise is a platform for development, deployment and management of secure mobile apps. In June 2014, Globo PLC acquired services division of Sourcebits Inc. more »

Share Price (AIM)
47.5p
Change
0.9  1.9%
P/E (fwd)
6.1
Yield (fwd)
n/a
Mkt Cap (£m)
177.5

Next Fifteen Communications Group plc is engaged in the provision of communications services. The Company operates in two segments: Integrated Communications and Specialist Agencies. Within the Integrated Communications segment, the Company operates five independent communications brands that function as autonomous businesses. These are Text 100, Bite Communications, The OutCast Agency, the Lexis Agency and M Booth. Its Specialist Agencies segment consists of Beyond Corporation Limited and Beyond International Corp (Beyond), with a focus on digital, Redshift Research Limited, which specializes in research, 463 Communications, LLC and Connections Media LLC focusing on public affairs and policy communications, and The Blueshirt Group, which operates in the investor and analyst relations field. more »

Share Price (AIM)
117.5p
Change
0.0  0.0%
P/E (fwd)
11.3
Yield (fwd)
2.6
Mkt Cap (£m)
71.5

First Derivatives plc is engaged in the provision of a range of software and consulting services to the investment bank market, the derivatives technology industry, the foreign exchange market and the provision of technology sales services to the information technology (IT) sector. The Company operates in two segments: consulting activities, which include services to capital markets, and software activities, which includes the sale of intellectual property and related services. Its software products are developed on the common Delta technology platform. Its legal services initiative provides resources to banks in areas, such as non-core asset disposal, regulatory compliance and securitization. The Company provided services to 100 different investment banks, brokers, exchanges and hedge funds. more »

Share Price (AIM)
892p
Change
-2.5  -0.3%
P/E (fwd)
21.2
Yield (fwd)
1.5
Mkt Cap (£m)
180.5



  Is Globo fundamentally strong or weak? Find out More »


3 Comments on this Article show/hide all

Tommy Rock 26th Nov '11 1 of 3
2

This view on IDS systems completely fails to understand the diagnostics market and shows the dangers of basing opinions on meaningless financial statements from self interested board members. Actually this company is extremely exposed to competition from Diasorin and Siemens both of whom have more advanced and attractive automated systems than the iSYS, a better test panel and much greater market penetration. The vast bulk of IDS income comes from vitamin D kit sales, a position which will be drastically eroded as Diasorin, Siemens, Roche and Abbots will pick up speed on their new kits. The major issue with iSYS is that is doesn't integrate with modern automated lab systems and has a none existent test panel, this leaves it isolated in the market.

| Link | Share
kevinsamvance 29th Nov '11 2 of 3

Don't forget Jim Slater also used three month, six month and 12 month Relative Strength as a signal to exit trades. On that basis he would not be holding GBO or IDH. SUN is doubtful but the other stocks pass the RS test.

| Link | Share
Tommy Rock 29th Nov '11 3 of 3

IDS £4.50 today down from £12 4 months ago!! well Jim, any suggestions?

| Link | Share

What's your view on this article? to Comment Now

 
 
You are feeling neutral

Use the £ sign in front of a ticker to turn £VOD into Vodafone PLC

You can track all @StockoChat comments via Twitter


About Ben Hobson

Ben Hobson

Follow

Strategies Editor at Stockopedia.  I make sure that Stockopedia is delivering the features that its members want to see.



Stock Picking Tutorial Centre



Stock Picking Simplified

Stockopedia takes your stock picking to the next level with cutting edge Stock Reports & Screening tools.


Get started
or Take a Tour to find out more.